Partner Headlines - MDCO

  1. Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: ...

    Investors Business Daily
  2. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets
  3. On The Fly: After Hours Movers - 11/8

    TalkMarkets
  4. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron ...

    TalkMarkets
  5. Jefferies Sees 'Attractive Buying Opportunities' In Biotech

    TalkMarkets
  6. Battleground: Alnylam Plunges After Revusiran Pulled, But Some ...

    TalkMarkets
  7. Medicines Co. up on sale talk

    IBD
  8. Mid-Afternoon Market Update: Dow Falls Over 400 Points; Advanced ...

    Benzinga
  9. Medicines Company Spikes On Report Of Possible Sale

    IBD
  10. Medicines Co Up For Sale? Bloomberg Info Comes Day After Benzinga ...

    Benzinga
  11. The Medicines Company Announces Investigational Lipid Modulating ...

    Benzinga
  12. Breakaway Gaps By Stocks Can Be Scary But Profitable

    IBD
  13. Benzinga's Top Initiations

    Benzinga
  14. Lilly Kills 'High Risk/High Reward' Cholesterol Drug

    IBD
  15. The Medicines Company Announces BARDA Exercises Next Option on ...

    Benzinga
  16. Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company ...

    Benzinga
  17. Mid-Day Market Update: Crude Oil Surges 5.5%; ConforMIS Shares ...

    Benzinga
  18. Benzinga's Volume Movers

    Benzinga
  19. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Benzinga's Top Upgrades

    Benzinga
  22. The Medicines Company Announces Participation at 2015 European ...

    Benzinga
  23. Volume And Volatility Alert: Medicines Company

    Benzinga
  24. Regeneron/Sanofi PCSK9 Cholesterol Drug Wins FDA OK

    IBD
  25. Medicines Co. gets upgrade

    IBD
  26. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD
  27. The Medicines Company Announces FDA Approval of KENGREAL as an ...

    Benzinga
  28. Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, ...

    GuruFocus
  29. FDA Advisory Committee Recommends Approval of The Medicines Company's ...

    Benzinga
  30. Blood clot preventer gets nod

    IBD
  31. Earnings Scheduled For February 18, 2015

    Benzinga
  32. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD
  33. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga
  34. Benzinga's Top Upgrades

    Benzinga
  35. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  36. What Investors Should Expect From Rockwell Medical's Next FDA ...

    Benzinga
  37. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops ...

    Benzinga
  38. Morning Market Losers

    Benzinga
  39. Tuesday's After-Hours Movers

    Benzinga
  40. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga
  41. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga
  42. The Medicines Company Announces First Patient Enrollment In Phase ...

    Benzinga
  43. Midday Gainers From October 28: Buffalo Wild Wings, Integrated ...

    Benzinga
  44. Morning Market Movers

    Benzinga
  45. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  46. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal ...

    Benzinga
  47. Actavis Expands Antibiotics Presence With Durata Buy

    IBD
  48. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  49. Benzinga's Top Downgrades

    Benzinga
  50. Benzinga's Top Downgrades

    Benzinga
  51. Medicines Co.

    IBD
  52. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  53. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  54. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  55. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  56. Stocks Hitting 52-Week Lows

    Benzinga
  57. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  58. Morning Market Losers

    Benzinga
  59. Benzinga's Top #PreMarket Losers

    Benzinga
  60. Medicines Co. earnings miss

    IBD
  61. Earnings Scheduled For February 19, 2014

    Benzinga
  62. FDA nixes Medicines' drug

    IBD
  63. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  64. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  65. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  66. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  67. Stocks Hitting 52-Week Lows

    Benzinga
  68. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  69. Benzinga's Top #PreMarket Losers

    Benzinga
  70. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  71. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  72. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  73. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  74. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  75. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  76. Medicines acquires Rempex

    IBD
  77. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  78. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  79. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  80. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  81. A Few Stocks Form Bases, But Have Flaws

    IBD
  82. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  83. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  84. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  85. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  86. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  87. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  88. Medicines Co. In Late Stages Of Base Formation

    IBD
  89. Medicines Co. sales topped

    IBD
  90. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  91. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  92. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  93. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  94. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  95. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  96. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  97. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  98. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  99. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  100. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
Trading Center